Abstract
Addiction, as a brain disorder, can be defined with two distinct but interacting components: drug dependency and neurocognitive deficits. Most of the therapeutic interventions in addiction medicine, including pharmacological or psychosocial therapies, that are in clinical use have been mainly focused on directly addressing addictive behaviors, especially drug use and urges to use drugs. In the field of addiction treatment, it is often presumed that drug users' neurocognitive deficits will reverse following abstinence. However, in many cases, neurocognitive deficits are not fully ameliorated following sustained abstinence, and neurocognitive function may further deteriorate in early abstinence. It can be argued that many cognitive functions, such as sustained attention and executive control, are essential for full recovery and long-term abstinence from addiction. Recent advances in cognitive neuroscience have provided scientific foundations for neurocognitive rehabilitation as a means of facilitating recovery from drug addiction. Neurocognitive rehabilitation for drug addicted individuals could be implemented as part of addiction treatment, with highly flexible delivery methods including traditional "paper and pencil" testing, o...Continue Reading
Citations
Dec 9, 2016·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Stefan T Samuelson, Ethan O Bryson
Dec 6, 2017·The Journal of Pharmacology and Experimental Therapeutics·William S JohnMichael A Nader
Jan 22, 2020·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Po-Wei LeeRu-Band Lu
Dec 21, 2019·Addiction Biology·Andreas HeinzRainer Spanagel
Apr 29, 2020·The American Journal of Drug and Alcohol Abuse·Aaron C LimLara A Ray
Jul 12, 2020·Journal of Music Therapy·Laurien HakvoortHein de Haan
Sep 28, 2018·Neuropsychology Review·Antonio Verdejo-GarcíaNatalia Albein-Urios
Jul 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Claudia Calpe-LópezMaria A Aguilar
Aug 24, 2019·Frontiers in Psychology·Simin Sadat AjtahedHamed Ekhtiari
Jan 11, 2020·Frontiers in Psychiatry·Antonio Verdejo-GarciaHamed Ekhtiari
Dec 20, 2017·Frontiers in Psychology·Gaëlle Challet-BoujuMarie Grall-Bronnec
Mar 21, 2019·Expert Review of Neurotherapeutics·Lucien Rochat, Yasser Khazaal
Feb 16, 2021·Journal of Psychopharmacology·Constanza de DiosScott D Lane
Nov 11, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Serenella TolomeoAlex Baldacchino
Apr 20, 2021·Neuropsychology Review·Talia NardoThomas Borchard
May 9, 2021·Trials·Hamed EkhtiariRobin Aupperle
Jun 19, 2021·Metabolic Brain Disease·Yasaman RazaviMehdi Mehdizadeh
Sep 8, 2021·Frontiers in Psychology·Tânia CaetanoMaria Dos Anjos Dixe
Sep 17, 2021·Frontiers in Psychiatry·Aldo Alberto Conti, Alexander Mario Baldacchino
Oct 26, 2021·Psychopharmacology·Parnian RafeiJavad Hatami